The charts on this telehealth stock point to strong gains ahead, according to Katie Stockton
After an explosive start to the year, Hims & Hers Health, Inc. (HIMS) is now trading in an intermediate-term range above long-term support from the weekly cloud model (shaded area on the chart) and the 200-day (~40-week) moving average, both of which define the stock’s cyclical uptrend. The uptrend remains healthy and is supported by…